These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 8167013)

  • 1. Role of Synonymous Mutations in the Evolution of TEM β-Lactamase Genes.
    Faheem M; Zhang CJ; Morris MN; Pleiss J; Oelschlaeger P
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. diskImageR: quantification of resistance and tolerance to antimicrobial drugs using disk diffusion assays.
    Gerstein AC; Rosenberg A; Hecht I; Berman J
    Microbiology (Reading); 2016 Jul; 162(7):1059-1068. PubMed ID: 27126388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin for the treatment of methicillin-resistant staphylococcal and enterococcal infections in 15 horses.
    Orsini JA; Snooks-Parsons C; Stine L; Haddock M; Ramberg CF; Benson CE; Nunamaker DM
    Can J Vet Res; 2005 Oct; 69(4):278-86. PubMed ID: 16479726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current perspectives on glycopeptide resistance.
    Woodford N; Johnson AP; Morrison D; Speller DC
    Clin Microbiol Rev; 1995 Oct; 8(4):585-615. PubMed ID: 8665471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources.
    Jensen KT; Schønheyder H; Pers C; Thomsen VF
    APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
    Felmingham D; Brown DF; Soussy CJ
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffusion of teicoplanin and vancomycin in agar.
    Cavenaghi LA; Biganzoli E; Danese A; Parenti F
    Diagn Microbiol Infect Dis; 1992; 15(3):253-8. PubMed ID: 1533826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tentative interpretative zone diameters for fusidic acid Neosensitabs on Mueller Hinton agar and three blood containing media.
    Skov R; Frimodt-Møller N; Espersen F
    Int J Antimicrob Agents; 2003 Nov; 22(5):502-7. PubMed ID: 14602369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
    Bezian MC; Ribou G; Masquelier B
    Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the agar medium and disc type on disc diffusion susceptibility testing against teicoplanin and vancomycin.
    Jensen KT; Schønheyder H; Gottschau A; Thomsen VF
    APMIS; 1994 Feb; 102(2):94-102. PubMed ID: 8167013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microenvironment in antibiotic susceptibility testing.
    Høiby N; Moser C; Ciofu O
    APMIS; 2024 Apr; ():. PubMed ID: 38565324
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.